HQH (abrdn Healthcare Investors) Stock Analysis - AI Report
abrdn Healthcare Investors (HQH) is a publicly traded Financial Services sector company. As of May 21, 2026, HQH trades at $20.00 with a market cap of $1.13B and a P/E ratio of 0.00. HQH moved +1.83% today. Year to date, HQH is +6.95%; over the trailing twelve months it is +23.46%. Its 52-week range spans $13.77 to $20.46. Rallies surfaces HQH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on HQH?
Rallies AI research for HQH combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
DiMartino Rose bought 1.00K (~$18.88K) on Jul 16, 2024.
Goetz Kathleen bought 525 (~$8.62K) on Apr 9, 2024.
Reit Todd bought 1.00K (~$16.93K) on Jan 2, 2024.
HQH Analyst Consensus
HQH analyst coverage data. Average price target: $0.00.
Common questions about HQH
What is the AI research view on HQH?
Rallies AI research for HQH combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for HQH?
Rallies AI research for HQH combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is HQH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HQH. It does not provide personalized investment advice.
